Numerous bioactive metabolites found in L. japonica can reduce the clinical symptoms in experimental IBD models by preventing the activation of NLRP3 inflammasomes, thus aiding in the improvement and treatment of IBD. This evidence concerns the gene NLRP3 and irritable bowel syndrome.